Mission Bio Launches Early Access Program for Single-Cell Measurable Residual Disease Detection in Blood Cancers
/PRNewswire/ -- Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis, today announced the initial availability of the industrys first...
Aaron Llanso Todd Druley Oxford Biomedica Consort Partners For Mission Bio Clinical Applications At Mission Bio Early Access Program
Source: prnewswire.com